BioNTech sees scope for further capacity expansion: CFO
The Mainz-based biotech company and its US partner Pfizer plan to produce 2.5 billion Covid-19 doses this year
The Mainz-based biotech company and its US partner Pfizer plan to produce 2.5 billion Covid-19 doses this year